Skip to main content

Published locations for ITC: Study provides first evidence of paclitaxel benefit for anaplastic thyroid cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ITC: Study provides first evidence of paclitaxel benefit for anaplastic thyroid cancer

User login

  • Reset your password
  • /content/itc-study-provides-first-evidence-paclitaxel-benefit-anaplastic-thyroid-cancer
  • /familypracticenews/article/104073/head-neck-cancers/itc-study-provides-first-evidence-paclitaxel
  • /internalmedicinenews/article/104073/head-neck-cancers/itc-study-provides-first-evidence-paclitaxel
  • /oncologypractice/article/104073/head-neck-cancers/itc-study-provides-first-evidence-paclitaxel
  • /clinicalendocrinologynews/article/104073/head-neck-cancers/itc-study-provides-first-evidence
  • /hematology-oncology/article/104073/head-neck-cancers/itc-study-provides-first-evidence-paclitaxel
  • /endocrinology/article/104073/head-neck-cancers/itc-study-provides-first-evidence-paclitaxel-benefit
  • /internalmedicine/article/104073/head-neck-cancers/itc-study-provides-first-evidence-paclitaxel
  • /familymedicine/article/104073/head-neck-cancers/itc-study-provides-first-evidence-paclitaxel-benefit